CANEPARO, Valeria
CANEPARO, Valeria
SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE
Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
2016-01-01 Alunno, Alessia ; Caneparo, Valeria; Bistoni, Onelia; Caterbi, Sara; Terenzi, Riccardo; Gariglio, Marisa; Bartoloni, Elena; Manzo, Antonio; Landolfo, Santo; Gerli, Roberto
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy
2016-01-01 Caneparo, Valeria; Pastorelli, Luca; Pisani, Laura Francesca; Bruni, Barbara; Prodam, Flavia; Boldorini, Renzo; Roggenbuck, Dirk; Vecchi, Maurizio; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco
Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed HPV8 Transgenic Mice
2022-01-01 Borgogna, Cinzia; Martuscelli, Licia; Olivero, Carlotta; Lo Cigno, Irene; De Andrea, Marco; Caneparo, Valeria; Boldorini, Renzo; Patel, Girish; Gariglio, Marisa
Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells
2022-01-01 Raviola S, Griffante G, Iannucci A, Caneparo V, Lacarbonara D, Chandel S, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M.
Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells
2024-01-01 Raviola, Stefano; Griffante, Gloria; Iannucci, Andrea; Chandel, Shikha; Lo Cigno, Irene; Lacarbonara, Davide; Caneparo, Valeria; Pasquero, Selina; Favero, Francesco; Corà, Davide; Trisolini, Elena; Boldorini, Renzo; Cantaluppi, Vincenzo; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco
IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data
2019-01-01 Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco
IFI16 Autoantibodies
2013-01-01 Dell’Oste, Valentina; Caneparo, Valeria; De Andrea Marco; Gariglio, Marisa; Landolfo, Santo
IL-6-mediated paracrine senescence drives the intercellular communication within the HCMV microenvironment in renal epithelial cells
2023-01-01 Raviola S, Iannucci A, Caneparo V, Lacarbonara D, Castiglioni F, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M.
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease
2019-01-01 Manfredi, Marcello; Conte, Eleonora; Barberis, Elettra; Buzzi, Arianna; Robotti, Elisa; Caneparo, Valeria; Cecconi, Daniela; Brandi, Jessica; Vanni, Ester; Finocchiaro, Marco; Astegiano, Marco; Gariglio, Marisa; Marengo, Emilio; De Andrea, Marco
Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
2015-01-01 Alunno, Alessia; Caneparo, Valeria; Carubbi, A; Bistoni, O; Caterbi; Gariglio, M; Bartoloni, E; Landolfo, S; Gerli, R;
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis?
2015-01-01 Alunno, Alessia; Caneparo, Valeria; Carubbi, Francesco; Bistoni, Onelia; Caterbi, Sara; Bartoloni, Elena; Giacomelli, Roberto; Gariglio, Marisa; Landolfo, Santo; Gerli, Roberto
P178 Validation of the clinical utility of IFI16-based markers in IBD
2017-01-01 V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea
P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
2018-01-01 Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study
2021-01-01 Griffante G.; Chandel S.; Ferrante D.; Caneparo V.; Capello D.; Bettio V.; Borgogna C.; Aleni C.; Esposito S.; Sarro A.; Vasile A.; Comba M.; Testa T.; Cotrupi G.; De Andrea M.; Bortoluzzi S.; Gariglio M.
Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al.
2017-01-01 Alunno, A; Bartoloni, E; Bistoni, O; Gerli, R; Caneparo, V; Carubbi, F; Landolfo, S
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes
2023-01-01 Marzano, Angelo V; Moltrasio, Chiara; Genovese, Giovanni; De Andrea, Marco; Caneparo, Valeria; Vezzoli, Pamela; Morotti, Denise; Sena, Paolo; Venturini, Marina; Battocchio, Simonetta; Caputo, Valentina; Rizzo, Nathalie; Maronese, Carlo Alberto; Venegoni, Luigia; Boggio, Francesca Laura; Rongioletti, Franco; Calzavara-Pinton, Piergiacomo; Berti, Emilio
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis
2020-01-01 De Andrea M.; De Santis M.; Caneparo V.; Generali E.; Sirotti S.; Isailovic N.; Guidelli G.M.; Ceribelli A.; Fabbroni M.; Simpatico A.; Cantarini L.; Gisondi P.; Idolazzi L.; Gariglio M.; Selmi C.
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes
2018-01-01 Caneparo, Valeria; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco
The PYRIN domain of IFI16 drives LPS-induced and sterile toll-like receptor 4-mediated inflammation
2023-01-01 Lacarbonara D, Iannucci A, Caneparo V, Raviola S, Martinello G, Miggiano R, Gariglio M, De Andrea M.
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD)
2017-01-01 Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis. | 2016 | Alunno, Alessia ; Caneparo, Valeria; Bistoni, Onelia; Caterbi, Sara; Terenzi, Riccardo; Gariglio, Marisa; Bartoloni, Elena; Manzo, Antonio; Landolfo, Santo; Gerli, Roberto | |
| Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy | 2016 | Caneparo, Valeria; Pastorelli, Luca; Pisani, Laura Francesca; Bruni, Barbara; Prodam, Flavia; Boldorini, Renzo; Roggenbuck, Dirk; Vecchi, Maurizio; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco | |
| Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed HPV8 Transgenic Mice | 2022 | Borgogna, Cinzia; Martuscelli, Licia; Olivero, Carlotta; Lo Cigno, Irene; De Andrea, Marco; Caneparo, Valeria; Boldorini, Renzo; Patel, Girish; Gariglio, Marisa | |
| Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells | 2022 | Raviola S, Griffante G, Iannucci A, Caneparo V, Lacarbonara D, Chandel S, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M. | |
| Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells | 2024 | Raviola, Stefano; Griffante, Gloria; Iannucci, Andrea; Chandel, Shikha; Lo Cigno, Irene; Lacarbonara, Davide; Caneparo, Valeria; Pasquero, Selina; Favero, Francesco; Corà, Davide; Trisolini, Elena; Boldorini, Renzo; Cantaluppi, Vincenzo; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco | |
| IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data | 2019 | Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco | |
| IFI16 Autoantibodies | 2013 | Dell’Oste, Valentina; Caneparo, Valeria; De Andrea Marco; Gariglio, Marisa; Landolfo, Santo | |
| IL-6-mediated paracrine senescence drives the intercellular communication within the HCMV microenvironment in renal epithelial cells | 2023 | Raviola S, Iannucci A, Caneparo V, Lacarbonara D, Castiglioni F, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M. | |
| Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease | 2019 | Manfredi, Marcello; Conte, Eleonora; Barberis, Elettra; Buzzi, Arianna; Robotti, Elisa; Caneparo, Valeria; Cecconi, Daniela; Brandi, Jessica; Vanni, Ester; Finocchiaro, Marco; Astegiano, Marco; Gariglio, Marisa; Marengo, Emilio; De Andrea, Marco | |
| Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands. | 2015 | Alunno, Alessia; Caneparo, Valeria; Carubbi, A; Bistoni, O; Caterbi; Gariglio, M; Bartoloni, E; Landolfo, S; Gerli, R; | |
| Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? | 2015 | Alunno, Alessia; Caneparo, Valeria; Carubbi, Francesco; Bistoni, Onelia; Caterbi, Sara; Bartoloni, Elena; Giacomelli, Roberto; Gariglio, Marisa; Landolfo, Santo; Gerli, Roberto | |
| P178 Validation of the clinical utility of IFI16-based markers in IBD | 2017 | V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea | |
| P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD | 2018 | Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M | |
| Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study | 2021 | Griffante G.; Chandel S.; Ferrante D.; Caneparo V.; Capello D.; Bettio V.; Borgogna C.; Aleni C.; Esposito S.; Sarro A.; Vasile A.; Comba M.; Testa T.; Cotrupi G.; De Andrea M.; Bortoluzzi S.; Gariglio M. | |
| Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al. | 2017 | Alunno, A; Bartoloni, E; Bistoni, O; Gerli, R; Caneparo, V; Carubbi, F; Landolfo, S | |
| SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes | 2023 | Marzano, Angelo V; Moltrasio, Chiara; Genovese, Giovanni; De Andrea, Marco; Caneparo, Valeria; Vezzoli, Pamela; Morotti, Denise; Sena, Paolo; Venturini, Marina; Battocchio, Simonetta; Caputo, Valentina; Rizzo, Nathalie; Maronese, Carlo Alberto; Venegoni, Luigia; Boggio, Francesca Laura; Rongioletti, Franco; Calzavara-Pinton, Piergiacomo; Berti, Emilio | |
| Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis | 2020 | De Andrea M.; De Santis M.; Caneparo V.; Generali E.; Sirotti S.; Isailovic N.; Guidelli G.M.; Ceribelli A.; Fabbroni M.; Simpatico A.; Cantarini L.; Gisondi P.; Idolazzi L.; Gariglio M.; Selmi C. | |
| The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes | 2018 | Caneparo, Valeria; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco | |
| The PYRIN domain of IFI16 drives LPS-induced and sterile toll-like receptor 4-mediated inflammation | 2023 | Lacarbonara D, Iannucci A, Caneparo V, Raviola S, Martinello G, Miggiano R, Gariglio M, De Andrea M. | |
| THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) | 2017 | Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R. |